LDL MDA-treated (15G2) Antibody

Abbiotec's LDL MDA-treated (15G2) Antibody is a Mouse monoclonal antibody (clone 15G2). The LDL MDA-treated (15G2) Antibody was generated using LDL as the antigen and it reacts with Human. This antibody has been shown to work in applications such as: Western Blot, ELISA. Low-density lipoprotein (LDL) is the carrier protein for cholesterol in the blood. LDL binds to its receptor on the capillary walls and thereby mediates the uptake and clearence of cholesterol from the circulation. In atherosclerotic lesions oxidatively modified LDL is found and oxidized LDL is specifically recognized and ingested by macrophages via scavenger receptor A and CD36. Oxidized LDL may be a marker of atherosclerosis but the precise changes in oxidized LDL are not well described. MDA-treated LDL appear to be different from LDL oxidized by other means. This antibody reacts with MDA-treated LDL but not with native LDL

  • Product Detail
  • All Images
Category Antibodies
Publication 0
Application ELISA, WB
Host Mouse
Reactivity Human
Clonality Monoclonal
immunogen Low-density lipoprotein purified from human plasma and treated with malonyldialdehyde (MDA)
Supplier Abbiotec
Isotype IgG2a kappa
Catalog Number 250413
Conjugation Unconjugated
Size 0.2 mg
Tissue Location http://www.abbiotec.com/antibodies/ldl-mda-treated-15g2-antibody

Images are not available.